Design Therapeutics, Inc. (DSGN) Free cash flow 2020–2025
Design Therapeutics, Inc. (DSGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$54.6MFY2025 · since FY2020: -$8.7M → -$54.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.6M | -25.6% |
| FY2024 | -$43.4M | +26.1% |
| FY2023 | -$58.8M | -12.6% |
| FY2022 | -$52.2M | -69.0% |
| FY2021 | -$30.9M | -253.5% |
| FY2020 | -$8.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice